[ 123 I]CC1: A PARP-Targeting, Auger Electron-Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer (2023)
Attributed to:
PET imaging of PARP using 18F-olaparib
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2967/jnumed.123.265429
PubMed Identifier: 37770109
Publication URI: http://europepmc.org/abstract/MED/37770109
Type: Journal Article/Review
Parent Publication: Journal of Nuclear Medicine
Issue: 12
ISSN: 0161-5505